Citigroup Inc ALNYLAM PHARMACEUTICALS INC Transaction History

Citigroup Inc

  • $196 Billion
  • Q2 2025
Number of Shares
136,000
Previous 2,128,000 93.61%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
N/A
-1,992,000 Reduced 93.61%
136,000 $0
Q1 2025

May 12, 2025
BUY
N/A
2,128,000 New
2,128,000 $0
Q3 2024

Nov 12, 2024
SELL
N/A
-3,123,000 Reduced 43.56%
4,046,000 $0
Q2 2024

Aug 12, 2024
BUY
N/A
4,602,000 Added 179.28%
7,169,000 $0
Q1 2024

May 10, 2024
BUY
N/A
1,297,000 Added 102.13%
2,567,000 $0
Q4 2023

Feb 09, 2024
BUY
N/A
1,270,000 New
1,270,000 $0
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email